![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/NATHBIOGEN.png)
Share the post "Nath Bio-Genes (India) ‘s Q2 Results: Profit Drops by 46.38% YoY"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 42.65 % in the past year, decrease in net sales/revenue by -86.8 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 22.58 %. Marginal decrease of -41.54% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Nath Bio-Genes (India) Limited. Profit dropped by -46.15 % Year to Year, Nath Bio-Genes (India) Limited’s profitability dropped by -96.66 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -38.37 % Year to Year. EPS decreased by -96.97 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 22.568 Cr | Rs. 243.875 Cr | Rs. 32.193 Cr | -86.8 % | + 42.65 % |
| Expenses | Rs. 17.05 Cr | Rs. 207.34 Cr | Rs. 27.38 Cr | -86.79 % | + 60.59 % |
| Operating Profit | Rs. 5.52 Cr | Rs. 36.54 Cr | Rs. 4.81 Cr | -86.84 % | -12.86 % |
| OPM % | 24.46 % | 14.98 % | 14.94 % | -0.04 % | -9.52 % |
| Other Income | Rs. 0.062 Cr | Rs. 0.13 Cr | Rs. 0.076 Cr | -41.54 % | + 22.58 % |
| Interest | Rs. 2.44 Cr | Rs. 2.24 Cr | Rs. 2.98 Cr | + 33.04 % | + 22.13 % |
| Depreciation | Rs. 0.76 Cr | Rs. 0.83 Cr | Rs. 0.83 Cr | + 0 % | + 9.21 % |
| Profit before tax | Rs. 2.38 Cr | Rs. 33.6 Cr | Rs. 1.08 Cr | -96.79 % | -54.62 % |
| Tax % | 14.5 % | 0.73 % | 2.58 % | + 1.85 % | -11.92 % |
| Net Profit | Rs. 2.07 Cr | Rs. 33.36 Cr | Rs. 1.11 Cr | -96.67 % | -46.38 % |
| EPS in Rs | Rs. 0.86 | Rs. 17.49 | Rs. 0.53 | -96.97 % | -38.37 % |
Today, we’re looking at Nath Bio-Genes (India) Limited’s financial performance for the Q2(Sep 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 42.65 %. However, it did see a marginal slip of -86.8 % from the previous quarter. Expenses decreased slightly by -86.79 % quarter-on-quarter, aligning with the annual rise of 60.59 %. Operating profit, while down -12.86 % compared to last year, faced a quarter-on-quarter dip of -86.84 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -9.52 %, but a shrinkage of -0.04 % sequentially. Other income fell by -41.54 % compared to the last quarter, despite an annual growth of 22.58 %. Interest expenses surged remarkably by 33.04 % from the previous quarter, yet the year-over-year increase remains at a moderate 22.13 %. Depreciation costs climbed by 0 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 9.21 %. Profit before tax declined annually by -54.62 % but saw a reduction from the preceding quarter by -96.79 %.
Tax expenses as a percentage of profits decreased slightly by -11.92 % compared to last year, with a more notable quarter-on-quarter increase of 1.85 %. Net profit fell by -46.38 % year-on-year but witnessed a -96.67 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -38.37 % but a quarterly fall of -96.97 %. In summary, Nath Bio-Genes (India) Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 22.568 Cr | Rs. 243.875 Cr | Rs. 32.193 Cr | -86.8 % | + 42.65 % |
| Expenses | Rs. 17.05 Cr | Rs. 207.34 Cr | Rs. 27.38 Cr | -86.79 % | + 60.59 % |
| Operating Profit | Rs. 5.52 Cr | Rs. 36.54 Cr | Rs. 4.81 Cr | -86.84 % | -12.86 % |
| Net Profit | Rs. 2.07 Cr | Rs. 33.36 Cr | Rs. 1.11 Cr | -96.67 % | -46.38 % |
| EPS in Rs | Rs. 0.86 | Rs. 17.49 | Rs. 0.53 | -96.97 % | -38.37 % |
In reviewing Nath Bio-Genes (India) Limited’s 2024(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 42.65 % year-on-year growth, although there was a slight dip of -86.8 % from the previous quarter. Expenses rose by 60.59 % compared to the previous year, with a decrease of -86.79 % quarter-on-quarter. Operating Profit dropped by -12.86 % annually, and saw a -86.84 % decrease from the last quarter.
Net Profit showed yearly decrease of -46.38 %, and experienced a -96.67 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -38.37 % annually, however dipped by -96.97 % compared to the last quarter. In essence, while Nath Bio-Genes (India) Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”Nath Bio-Genes (India) Limited”]
